Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Metabolic Health

Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes

N. Irwin; V. A. Gault; F. P. M. O'Harte; P. R. Flatt Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes Peptides
Insulin Resistance & Diabetes

Metabolomics in the developmental origins of obesity and its cardiometabolic consequences

M. F. Hivert; W. Perng; S. M. Watkins; C. S. Newgard; L. C. Kenny; B. S. Kristal; M. E. Patti; E. Isganaitis; D. L. DeMeo; E. Oken; M. W. Gillman Metabolomics in the developmental origins of obesity and its cardiometabolic consequences J Dev Orig Health Dis

New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders

N. Irwin; P. R. Flatt New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders World J Diabetes
Insulin Resistance & Diabetes

Emerging therapeutic potential for xenin and related peptides in obesity and diabetes

S. L. Craig; V. A. Gault; N. Irwin Emerging therapeutic potential for xenin and related peptides in obesity and diabetes Diabetes Metab Res Rev
Insulin Resistance & Diabetes

Impact of anti-inflammatory nutrients on obesity-associated metabolic-inflammation from childhood through to adulthood

R. M. Connaughton; A. M. McMorrow; F. C. McGillicuddy; F. E. Lithander; H. M. Roche Impact of anti-inflammatory nutrients on obesity-associated metabolic-inflammation from childhood through to adulthood Proc Nutr Soc
Insulin Resistance & Diabetes

Recent advances in peptide-based therapy for Type 2 diabetes and obesity

J. M. Conlon; P. R. Flatt; C. J. Bailey Recent advances in peptide-based therapy for Type 2 diabetes and obesity Peptides
Insulin Resistance & Diabetes

Dual-agonist incretin peptides from fish with potential for obesity-related Type 2 diabetes therapy – A review

J. M. Conlon; F. P. M. O'Harte; P. R. Flatt Dual-agonist incretin peptides from fish with potential for obesity-related Type 2 diabetes therapy – A review Peptides
Insulin Resistance & Diabetes

Metabolic signature of obesity-associated insulin resistance and type 2 diabetes

H. Al-Sulaiti; I. Diboun; M. V. Agha; F. F. S. Mohamed; S. Atkin; A. S. Dömling; M. A. Elrayess; N. A. Mazloum Metabolic signature of obesity-associated insulin resistance and type 2 diabetes J Transl Med
Insulin Resistance & Diabetes

Dysfunctional epicardial adipose tissue (EAT) and maladaptive heart remodeling in patients with increased visceral adiposity: the ST2/IL-33 cardio-fat signaling

E. Vianello; E. Dozio; L. Tacchini; J. Lamont; F. Bandera; M. M. Corsi Romanelli Dysfunctional epicardial adipose tissue (EAT) and maladaptive heart remodeling in patients with increased visceral adiposity: the ST2/IL-33 cardio-fat signaling J Biol Regul Homeost Agents

Endogenous oils derived from human adipocytes are potent adjuvants that promote IL-1α-dependent inflammation

G. A. Tynan; C. H. Hearnden; E. Oleszycka; C. L. Lyons; G. Coutts; J. O'Connell; M. A. Corrigan; L. Lynch; M. Campbell; J. J. Callanan; K. H. Mok; J. Geoghegan; C. O'Farrelly; S. M. Allan; H. M. Roche; D. B. O'Shea; E. C. Lavelle Endogenous oils derived from human adipocytes are potent adjuvants that promote IL-1α-dependent inflammation Diabetes

Older posts

Newer posts

← Previous Page1 … Page10 Page11 Page12 … Page54 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2025 ASOI